China Biologics Market: The Rise of Innovative Biopharmaceutical Solutions
The growth of the China Biologics Market is deeply intertwined with the rise of biosimilars. As many original biologics face patent expirations, local Chinese manufacturers are stepping in with high-quality, cost-effective alternatives. This has been instrumental in increasing patient access, as these medications allow healthcare systems to treat a significantly larger number of patients within...
0 Comments 0 Shares 83 Views 0 Reviews